These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 2571416)

  • 21. Preliminary evidence for inhibitory effect of glycyrrhizin on HIV replication in patients with AIDS.
    Hattori T; Ikematsu S; Koito A; Matsushita S; Maeda Y; Hada M; Fujimaki M; Takatsuki K
    Antiviral Res; 1989; 11(5-6):255-61. PubMed ID: 2572198
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel, negatively charged, human serum albumins display potent and selective in vitro anti-human immunodeficiency virus type 1 activity.
    Jansen RW; Schols D; Pauwels R; De Clercq E; Meijer DK
    Mol Pharmacol; 1993 Nov; 44(5):1003-7. PubMed ID: 7902528
    [TBL] [Abstract][Full Text] [Related]  

  • 23. AIDS and related disorders.
    Yarchoan R; Masur H; Broder S
    Cancer Chemother Biol Response Modif; 1988; 10():182-209. PubMed ID: 3079383
    [No Abstract]   [Full Text] [Related]  

  • 24. Cerebrospinal fluid human immunodeficiency virus type 1 RNA levels are elevated in neurocognitively impaired individuals with acquired immunodeficiency syndrome. HIV Neurobehavioral Research Center Group.
    Ellis RJ; Hsia K; Spector SA; Nelson JA; Heaton RK; Wallace MR; Abramson I; Atkinson JH; Grant I; McCutchan JA
    Ann Neurol; 1997 Nov; 42(5):679-88. PubMed ID: 9392566
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antiretroviral drug treatment for HIV/AIDS.
    Goldschmidt RH; Moy A
    Am Fam Physician; 1996 Aug; 54(2):574-80, 587-8. PubMed ID: 8701838
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Future possibilities of drug therapy of acquired immunodeficiency syndrome].
    Bálint GS
    Orv Hetil; 1994 Jun; 135(23):1235-42. PubMed ID: 8015818
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Experimental chemotherapy of AIDS].
    Rada B
    Cas Lek Cesk; 1988 May; 127(22):677-83. PubMed ID: 3293790
    [No Abstract]   [Full Text] [Related]  

  • 28. [Attempts at the treatment of acquired immunodeficiency syndrome (AIDS)].
    Turek-Urasińska K
    Pol Tyg Lek; 1987 Dec; 42(49):1551-3. PubMed ID: 3330216
    [No Abstract]   [Full Text] [Related]  

  • 29. [HIV protease inhibitors (new possibilities in the treatment of HIV infection and AIDS)].
    Bálint GS
    Orv Hetil; 1998 Jun; 139(24):1471-4. PubMed ID: 9658865
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Antiviral chemotherapy for AIDS: dideoxynucleosides and clinical application].
    Shiraska T; Yarchoan R; Mitsuya H
    Nihon Rinsho; 1990 Sep; 48(9):2141-50. PubMed ID: 2232220
    [No Abstract]   [Full Text] [Related]  

  • 31. Protection of T cells against infectivity and cytopathic effect of HTLV-III in vitro.
    Mitsuya H; Matsushita S; Yarchoan R; Broder S
    Princess Takamatsu Symp; 1984; 15():277-88. PubMed ID: 6085846
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Are we winning the battle against the human immunodeficiency virus.
    Sullivan AK; Nelson MR
    Br J Hosp Med; 1997 Nov 19-Dec 9; 58(10):486-8. PubMed ID: 10193449
    [No Abstract]   [Full Text] [Related]  

  • 33. [Therapeutic aspects of HIV/AIDS infected patients and evaluation of therapeutic protocols].
    Reszketö Z; Szlávik J; Balogh J; Vincze Z
    Acta Pharm Hung; 2001 Dec; 71(4):428-32. PubMed ID: 12113183
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Polysulfonated polysaccharides. Inhibitors against AIDS in clinical evaluation].
    Fortschr Med; 1989 Feb; 107(5):13. PubMed ID: 2468590
    [No Abstract]   [Full Text] [Related]  

  • 35. Non-nucleoside reverse transcriptase inhibitors (NNRTIs) for the treatment of human immunodeficiency virus type 1 (HIV-1) infections: strategies to overcome drug resistance development.
    de Clercq E
    Med Res Rev; 1996 Mar; 16(2):125-57. PubMed ID: 8656777
    [No Abstract]   [Full Text] [Related]  

  • 36. [Therapeutic potential of Ro 5-3335. New active benzodiazepine in vitro against HIV-1 viruses resistant or non-resistant to AZT].
    Camsonne R; Bigot MC; Fusibet H; Moulin MA
    Therapie; 1993; 48(2):105-7. PubMed ID: 8351676
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-HIV activity of extracts and compounds from algae and cyanobacteria.
    Schaeffer DJ; Krylov VS
    Ecotoxicol Environ Saf; 2000 Mar; 45(3):208-27. PubMed ID: 10702339
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Current clinical aspects of AIDS].
    Clumeck N
    Bull Mem Acad R Med Belg; 1993; 148(5-6):234-9; discussion 240-1. PubMed ID: 8142932
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 3TC approval may revive AZT's appeal.
    Vazquez E
    Posit Aware; 1996; 7(1):8-9. PubMed ID: 11363136
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiviral drug development for the treatment of human immunodeficiency virus infections. An overview.
    Hirsch MS
    Am J Med; 1988 Aug; 85(2A):182-5. PubMed ID: 3044083
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.